AUDUBON, PA, August 3, 2012: Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced the pricing of its initial public offering of 8,333,333 shares of Class A common stock at a price of $12 per share, consisting of 2,083,333 shares offered by Globus Medical and 6,250,000 shares offered by selling stockholders. In addition, Globus Medical has granted the underwriters a 30-day option to purchase up to an additional 1,250,000 shares of common stock to cover any over-allotments. Closing of the offering is expected to occur on August 8, 2012, subject to customary closing conditions. The shares are expected to begin trading on the New York Stock Exchange today under the symbol GMED.
BofA Merrill Lynch, Goldman, Sachs & Co., and Piper Jaffray are acting as lead joint book-running managers for the offering, Leerink Swann is acting as a junior book-running manager for the offering, and Canaccord Genuity, William Blair, and Oppenheimer & Co. Inc. are acting as co-managers for the offering.
The offering will be made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from: Merrill Lynch, Pierce, Fenner & Smith Incorporated at 1-212-449-1668, Goldman, Sachs & Co. at 1-866-471-2526 or Piper Jaffray & Co. at 1-800-747-3924.
A registration statement related to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission. This pres release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.